Cellectis
CLLS
65 hedge funds and large institutions have $191M invested in Cellectis in 2018 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 18 increasing their positions, 20 reducing their positions, and 28 closing their positions.
0.07% less ownership
Funds ownership: 27.35% → 27.28% (-0.07%)
10% less repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 20
20% less funds holding
Funds holding: 81 → 65 (-16)
41% less capital invested
Capital invested by funds: $325M → $191M (-$134M)
54% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 28
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$7.43M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
+$5.65M |
| 3 |
Capital International Investors
Los Angeles,
California
|
+$5.55M |
| 4 |
RCMNY
Rubric Capital Management (New York)
New York
|
+$2.77M |
| 5 |
New York State Common Retirement Fund
Albany,
New York
|
+$2.31M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
-$4.64M |
| 2 |
LCM
Laurion Capital Management
New York
|
-$3.8M |
| 3 |
Morgan Stanley
New York
|
-$3.39M |
| 4 |
SAM
Stansberry Asset Management
Westlake,
Texas
|
-$3.11M |
| 5 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$3.1M |
CLLS Hedge Fund Activity: Q4 2018 in Review
65 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Cellectis (CLLS) for Q4 2018, worth a combined $191M — down 41% from $325M a quarter earlier.
Sellers outnumbered buyers: 28 funds closed out of CLLS and 13 opened new positions — a net loss of 15 holders — while 20 trimmed existing stakes and 18 added.
The largest buyer was ARK Investment Management, adding an estimated $7.43M. The largest seller was Adage Capital Partners, cutting an estimated $4.64M.
- 65 institutional investors held Cellectis (CLLS) as of Q4 2018, down from 81 in Q3 2018.
- Funds reported $191M of Cellectis stock for Q4 2018, down 41% quarter-over-quarter.
- 13 funds opened new Cellectis positions in Q4 2018 and 28 closed out, a net change of -15 holders.
- The largest Cellectis buyer in Q4 2018 was ARK Investment Management, an estimated $7.43M added.
- The largest Cellectis seller in Q4 2018 was Adage Capital Partners, an estimated $4.64M sold.
Based on aggregated 13F filings for Q4 2018.